Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5851]

SABCS 2016: BELLE-3 trial meets primary endpoint of progression-free survival for breast cancer

SABCS 2016: BELLE-3 trial meets primary endpoint of progression-free survival for breast cancer

Stem cell-based test predicts leukaemia patients' response to therapy to tailor treatment

Stem cell-based test predicts leukaemia patients' response to therapy to tailor treatment

FDA approves bevacizumab with chemotherapy for platinum-sensitive ovarian cancer

FDA approves bevacizumab with chemotherapy for platinum-sensitive ovarian cancer

Personalised cancer vaccine associated with promising outcomes for AML patients

Personalised cancer vaccine associated with promising outcomes for AML patients

Fat intake shows link to metastasis

Fat intake shows link to metastasis

SABCS 2016 : Adding everolimus to fulvestrant improved outcomes for postmenopausal patients with HR-positive breast cancer

SABCS 2016 : Adding everolimus to fulvestrant improved outcomes for postmenopausal patients with HR-positive...

SABCS 2016: Extended letrozole therapy showed limited benefit in postmenopausal women with early-stage, HR-positive breast cancer

SABCS 2016: Extended letrozole therapy showed limited benefit in postmenopausal women with early-stage, HR...

SABCS 2016: Genomic sequencing of treatment-resistant metastatic breast cancer reveals clinically relevant genetic alterations

SABCS 2016: Genomic sequencing of treatment-resistant metastatic breast cancer reveals clinically relevant genetic...

ASH 2016: IKZF1 mutations found to increase hereditary risk for ALL in children

ASH 2016: IKZF1 mutations found to increase hereditary risk for ALL in children

ASH 2016: Nivolumab with chemotherapy improves response, survival in AML study patients

ASH 2016: Nivolumab with chemotherapy improves response, survival in AML study patients

More from ecancer